Avalo Therapeutics Inc

General ticker "AVTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $59.5M

Avalo Therapeutics Inc follows the US Stock Market performance with the rate: 18.6%.

Estimated limits based on current volatility of 5.5%: low 8.45$, high 9.44$

Factors to consider:

  • Current price 13.3% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [10.16$, 31.48$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.86$, 17.81$]

Financial Metrics affecting the AVTX estimates:

  • Negative: Non-GAAP EPS, $ of -485.26 <= 0.10
  • Negative: Operating profit margin, % of -92.42 <= 1.03
  • Negative: Operating cash flow per share per price, % of -88.53 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term AVTX quotes

Long-term AVTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $5.40MM $18.05MM $1.92MM
Operating Expenses $87.53MM $55.49MM $25.37MM
Operating Income $-82.13MM $-37.44MM $-23.44MM
Non-Operating Income $-2.41MM $-4.19MM $-8.09MM
Interest Expense $2.39MM $4.17MM $3.42MM
R&D Expense $59.84MM $31.31MM $13.78MM
Income(Loss) $-84.55MM $-41.63MM $-31.53MM
Taxes $-0.20MM $0.03MM $0.01MM
Other Income(Loss) $-0.03MM $0.00MM $0.00MM
Profit(Loss) $-84.38MM $-41.66MM $-31.54MM
Stockholders Equity $23.08MM $-10.91MM $7.30MM
Inventory $0.04MM $0.02MM $0.00MM
Assets $80.21MM $33.37MM $20.99MM
Operating Cash Flow $-70.89MM $-26.75MM $-30.68MM
Capital expenditure $0.11MM $0.10MM $0.16MM
Investing Cash Flow $-0.11MM $-0.10MM $-0.13MM
Financing Cash Flow $106.76MM $-14.70MM $25.04MM
Earnings Per Share* $-2,330.66 $-1,062.65 $-113.58

* EPS are Split Adjusted, recent splits may be reflected with a delay.